Issue 1 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

1

January 13, 2006Jan 13, 2006

Free

DOWNLOAD THE PDF

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds.

NCI Establishes New Program Project Grant Guidelines.

Chemotherapy Pioneer Howard Skipper Dead; His Work With Lekemia Cells In Mice Led To Development of Combination Therapies.

Recent Issues

Volume 52 | Issue 41 - November 06, 2026

Volume 52 | Issue 40 - October 30, 2026

Volume 52 | Issue 39 - October 23, 2026

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026